Sematrinity 2 mg is an injectable medication thats used to treat chronic weight management problems in adults, type 2 diabetes, and fatty liver diseases like MASH
As prices come down, the addressable market could expand significantly, especially in urban centres, said Rajesh Pherwani, Founder and Chief Investment Officer at Valcreate Investment Managers LLP
Originally derived from gastric proteins, it helps strengthen the GI barrier and support digestive balance
This product is FDA-approved and manufactured to meet United States Pharmacopeia (USP) monograph standards and current Good Manufacturing Practice (cGMP) requirements
However, you are NOT a good candidate for semaglutide if you have any of the following: diabetic retinopathy, low blood sugar, decreased kidney function, pancreatitis, medullary thyroid cancer (or a family history of medullary thyroid carcinoma), or multiple endocrine neoplasia type 2
Alston, E.C